Amkor Technology, Inc. (AMKR) financials
NASDAQ · Technology · Semiconductors · 30,800 employees · CEO Kevin K. Engel
- Price
- $39.50 -4.15%
- Market cap
- $9.79B
- Enterprise value
- $10.8B
- Last report
- Q3 '26 filed 2026-10-27
- Next report
- 2027-02-08 EPS est. $0.71
Valuation & key figures
- Market cap
- $9.79B EV $10.8B
- Revenue
- $7.46B Trailing 12 months
- Revenue growth
- +13% FY2026 consensus
- Profit margin
- 8.3% Net income / revenue, TTM
- P/E
- 15.8× Forward 15.6× (FY2026)
- P/S
- 1.3× Price / sales, TTM
- EV / EBITDA
- 7.3× TTM
- Free cash flow
- $532M Trailing 12 months
- Net income
- $619M Trailing 12 months
- Revenue estimate
- $7.59B FY2026 consensus
- Earnings
- 2027-02-08 Revenue est. $1.99B
- Dividend
- $0.33 Per share, last 12 months
Key takeaways
Computed from the reported numbers - every statement carries the figure it rests on.
- Last report (2026-10-26): revenue missed by 2.3%, EPS missed by 2.9%Revenue $1.99B vs $2.04B expected (-2.3%); EPS $0.76 vs $0.78 (-2.9%).
- Revenue growth slowing: 0.2% year on yearQ3 '26 revenue $1.99B, against an average of 18.9% over the four quarters before.
- Operating margin 9.5% (TTM), +3.0 pp on a year agoOperating income grew 70.3% while revenue grew 15.7%.
- Capex 13.1% of revenue (a year ago 11.8%)$980M invested in the last 4 quarters (+29.3% on a year earlier). Free cash flow $532M = 85.9% of net income.
- Returned $115M to shareholders = 21.6% of free cash flowBuybacks $32.3M (a year earlier $0), dividends $82.7M, stock-based pay $0 (TTM).
- Diluted share count up 0.5% in a year250M diluted shares in Q3 '26, 248M a year earlier.
- Net debt $218MCash + short-term investments $2.38B, debt incl. leases $2.59B; a year ago net cash $90.1M.
Last quarter: Q3 '26
Quarter ended 2026-09-30. Compared with the same quarter a year earlier and with the analyst consensus before the report.
Quarter vs a year ago
| Q3 '26 | Year ago | Change | |
|---|---|---|---|
| Revenue | $1.99B | $1.99B | +0.2% |
| Gross margin | 18.3% | 14.3% | +3.9 pp |
| Operating income | $225M | $159M | +41.4% |
| Operating margin | 11.3% | 8.0% | +3.3 pp |
| Net income | $191M | $127M | +50.6% |
| Diluted EPS | $0.76 | $0.51 | +49.0% |
| Operating cash flow | $487M | $169M | +188.9% |
| Capex | $548M | $246M | +122.5% |
| Free cash flow | -$61.6M | -$77.9M | +20.9% |
| R&D | $39.8M | $42.4M | -6.0% |
| Stock-based compensation | $0 | $0 | – |
Reported vs consensus
2026-10-26| Actual | Consensus | vs consensus | |
|---|---|---|---|
| Revenue | $1.99B | $2.04B | -2.3% |
| EPS (as estimated) | $0.76 | $0.78 | -2.9% |
From the report of 2026-10-26 for Q3 '26: revenue and the EPS analysts estimate (often adjusted), so it can differ from the EPS of the statements above.
EPS vs consensus
last 8 reportsRevenue
Where the money comes from - by business line and by region, quarter by quarter.
Revenue, operating income and growth
quarterlyRevenue by business line
stacked, quarterly| Segment | Q3 '26 | y/y | Share | TTM | TTM y/y | 12 quarters |
|---|---|---|---|---|---|---|
| Advanced Products | $1.63B | -3.1% | 82.0% | $6.14B | +15.1% | |
| Mainstream Products | $359M | +18.3% | 18.0% | $1.32B | +18.4% |
Margins & cost structure
How much of each unit of revenue is left at each level - and where the costs go.
Margins
quarterlyCosts as % of revenue
quarterlyCash flow & capital allocation
Cash generated, what it is spent on, and what reaches shareholders.
Operating cash flow, capex, free cash flow
quarterlyUses of cash vs operating cash flow
fiscal yearsLast 4 quarters
cash flow statement- Operating cash flow
- $1.51B
- Capex
- -$980M
- Buybacks
- -$32.3M
- Dividends
- -$82.7M
- Acquisitions
- $105M
- Net debt issued
- $585M
- Stock-based compensation
- $0
- Free cash flow
- $532M
- Returned to shareholders / FCF
- 21.6%
Share count and EPS
quarterly, dilutedBalance sheet
Liquidity, investments and debt at each quarter end.
Cash, investments and debt
quarter endsValuation & returns
Today's multiples against the company's own last five fiscal years; analyst targets and ratings.
Multiples and returns
TTM vs 5 fiscal years| Now | 5y average | Where today sits in the 5-year range | |
|---|---|---|---|
| P/E (TTM) | 15.8× | 16.8× | 7.7× – 26.1× |
| EV / EBITDA | 7.3× | 6.3× | 4.3× – 8.6× |
| EV / Sales | 1.4× | 1.2× | 0.9× – 1.5× |
| Price / FCF | 18.4× | 26.7× | 15.7× – 51.1× |
| Price / Book | 2.0× | 1.9× | 1.5× – 2.2× |
| FCF yield | 5.4% | 4.5% | 2.0% – 6.4% |
| Return on invested capital | 7.6% | 9.8% | 6.0% – 15.0% |
| Return on equity | 13.4% | 13.7% | 8.4% – 21.9% |
Analysts
Consensus target $66.00 (+67.1%)
range $55.00 – $90.00 · rating Buy
Outlook
Analyst consensus for the coming fiscal years and what it implies at today's price.
Consensus estimates
| Fiscal year | Revenue | Growth | EPS | Growth | P/E at today's price | Analysts (EPS) |
|---|---|---|---|---|---|---|
| FY2026 | $7.59B | +13.1% | $2.53 | +69.0% | 15.6× | 6 |
| FY2027 | $8.59B | +13.2% | $2.77 | +9.2% | 14.3× | 7 |
| FY2028 | $9.54B | +11.0% | $3.22 | +16.1% | 12.3× | 7 |
| FY2029 | $10.5B | +10.0% | $3.33 | +3.4% | 11.9× | 2 |
| FY2030 | $11.7B | +11.8% | $0.00 | -100.0% | – | 4 |
Financial statements
Every line of the income statement, balance sheet and cash flow statement - 12 quarters and 10 fiscal years, as values, as % of revenue or as growth.
Every reported line
All 322 figures Amkor Technology, Inc. tagged in its recent 10-Q / 10-K filings, with the official SEC label and definition - including the notes (leases, taxes, buybacks, employees, ...).
| Line (SEC label) | Latest quarter | Year ago | y/y | Latest FY | Prior FY | y/y |
|---|---|---|---|---|---|---|
| Accounts Payable, Current | $926M | $925M | +0.1% | $913M | $713M | +28.0% |
| Accounts Receivable, after Allowance for Credit Loss, Current | $1.51B | $1.4B | +8.0% | $1.35B | $1.06B | +28.4% |
| Accounts Receivable, Allowance for Credit Loss, Current | $1.03M2025-12-31 | $1.32M | -22.0% | $1.03M | $1.32M | -22.0% |
| Accrued Income Taxes, Current | $104M | $49.1M | +111.6% | $32.8M | $35.1M | -6.3% |
| Accrued Liabilities, Current | $535M | $395M | +35.4% | $370M | $356M | +3.9% |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | $15.9M | $11.9M | +33.5% | $16.8M | $7.51M | +124.1% |
| Additional Paid in Capital | $2.04B | $2.05B | -0.5% | $2.05B | $2.03B | +1.1% |
| Amortization of Debt Issuance Costs and Discounts | – | – | – | $3.6M | $3.53M | +2.0% |
| Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | 22K2026-03-31 | 38K | -42.1% | 7,000 | 0 | – |
| APIC, Share-based Payment Arrangement, Increase for Cost Recognition | $6.45M | $5.14M | +25.4% | $20.1M | $18.4M | +9.4% |
| Area of Land | – | – | – | 56 acre2024-12-31 | – | – |
| Assets | $10B | $8.19B | +22.7% | $8.14B | $6.94B | +17.2% |
| Assets for Plan Benefits, Defined Benefit Plan | $11.1M2025-12-31 | $5.99M | +85.9% | $11.1M | $5.99M | +85.9% |
| Assets, Current | $4.62B | $4.01B | +15.3% | $3.88B | $3.07B | +26.4% |
| Capital Expenditures Incurred but Not yet Paid | -$95.1M | -$29.4M | -223.4% | $238M | $118M | +101.7% |
| Cash and Cash Equivalents, at Carrying Value | $1.6B | $1.5B | +7.2% | $1.38B | $1.13B | +21.6% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $1.8B | $1.56B | +16.0% | $1.45B | $1.13B | +27.5% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $64.4M | $28.3M | +127.8% | $312M | $13.7M | +2,176.8% |
| Common Stock, Dividends, Per Share, Declared | $0.08 | $0.08 | +1.0% | $0.33 | $0.72 | -54.2% |
| Common Stock, Par or Stated Value Per Share | $0.00 | $0.00 | 0.0% | $0.00 | $0.00 | 0.0% |
| Common Stock, Shares Authorized | 500M | 500M | 0.0% | 500M | 500M | 0.0% |
| Common Stock, Shares, Issued | 295M | 294M | +0.5% | 294M | 293M | +0.2% |
| Common Stock, Shares, Outstanding | 248M | 247M | +0.2% | 247M | 247M | +0.3% |
| Common Stock, Value, Issued | $295K | $294K | +0.3% | $294K | $293K | +0.3% |
| Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest | $306K | $93K | +229.0% | $2.22M | $1.52M | +45.8% |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent | $191M | $126M | +51.7% | $383M | $345M | +11.0% |
| Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest | $192M | $126M | +51.8% | $385M | $347M | +11.2% |
| Concentration Risk, Percentage | 100.0% | 100.0% | 0.0% | – | – | – |
| Contract with Customer, Liability | $548M | $83.1M | +559.0% | $391M | $95.6M | +308.8% |
| Contract with Customer, Liability, Current | $127M | $56.2M | +126.6% | $69.6M | $59.7M | +16.7% |
| Contract with Customer, Liability, Revenue Recognized | $18.5M | $12.1M | +52.9% | $64.3M | $66M | -2.6% |
| Cost of Goods and Services Sold | $1.63B | $1.7B | -4.4% | $5.77B | $5.38B | +7.1% |
| Current Federal Tax Expense (Benefit) | – | – | – | $27M | $7.9M | +242.2% |
| Current Foreign Tax Expense (Benefit) | – | – | – | $60.5M | $68.3M | -11.5% |
| Current Income Tax Expense (Benefit) | – | – | – | $87.5M | $76.3M | +14.8% |
| Current State and Local Tax Expense (Benefit) | – | – | – | $21K | $34K | -38.2% |
| Debt Instrument, Collateral Amount | $846M | $924M | -8.4% | $956M | $640M | +49.5% |
| Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net | -$28.6M | -$11.8M | -141.5% | -$10.9M | -$5M | -118.4% |
| Debt Securities, Available-for-sale, Amortized Cost, Current | $778M | $614M | +26.8% | $612M | $513M | +19.3% |
| Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 | $7.06M2025-12-31 | – | – | $7.06M | – | – |
| Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five | $266M | $200M | +33.2% | $218M | $158M | +37.4% |
| Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One | $1.13B | $1.24B | -8.5% | $762M | $493M | +54.5% |
| Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 | $7.06M2025-12-31 | – | – | $7.06M | – | – |
| Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five | $262M | $200M | +30.9% | $218M | $159M | +37.5% |
| Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One | $1.13B | $1.24B | -8.6% | $762M | $494M | +54.5% |
| Debt, Current | $150M | $547M | -72.7% | $162M | $236M | -31.2% |
| Debt, Long-term and Short-term, Combined Amount | $2.5B | $1.82B | +36.8% | $1.46B | $1.16B | +25.1% |
| Deferred Federal Income Tax Expense (Benefit) | – | – | – | -$13.2M | $153K | -8,733.3% |
| Deferred Foreign Income Tax Expense (Benefit) | – | – | – | -$5.84M | -$436K | -1,240.4% |
| Deferred Income Tax Assets, Net | $86.4M2025-12-31 | $72.5M | +19.2% | $86.4M | $72.5M | +19.2% |
| Deferred Income Tax Expense (Benefit) | – | – | – | -$19M | -$784K | -2,325.1% |
| Deferred Income Tax Liabilities, Net | $11.4M2025-12-31 | $16.6M | -31.4% | $11.4M | $16.6M | -31.4% |
| Deferred State and Local Income Tax Expense (Benefit) | – | – | – | $40K | -$501K | +108.0% |
| Deferred Tax Assets, Gross | $213M2025-12-31 | $228M | -6.6% | $213M | $228M | -6.6% |
| Deferred Tax Assets, Net | $75M2025-12-31 | $55.9M | +34.2% | $75M | $55.9M | +34.2% |
| Deferred Tax Assets, Net of Valuation Allowance | $133M2025-12-31 | $121M | +10.6% | $133M | $121M | +10.6% |
| Deferred Tax Assets, Operating Loss Carryforwards | $22.5M2025-12-31 | $21.4M | +5.0% | $22.5M | $21.4M | +5.0% |
| Deferred Tax Assets, Other | $12.9M2025-12-31 | $14.2M | -9.2% | $12.9M | $14.2M | -9.2% |
| Deferred Tax Assets, Property, Plant and Equipment | $20M2025-12-31 | $18.5M | +8.3% | $20M | $18.5M | +8.3% |
| Deferred Tax Assets, Tax Credit Carryforwards | $78.3M2025-12-31 | $69.4M | +12.9% | $78.3M | $69.4M | +12.9% |
Source: SEC companyfacts (XBRL of every 10-Q / 10-K). Cash-flow quarters are derived from the year-to-date figures the 10-Q tags. Segment breakdowns are tagged with dimensions and are shown in the segment section instead.
Sources
Statements, segment revenue, metrics and estimates are standardised from the company's filings. Segment profits and every reported line: SEC EDGAR (XBRL). Filings read: 10-Q 2026-09-30, 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31, 10-Q 2024-09-30
Data as of 2026-11-02